Skip to contentClarengateINTELLIGENCE
Companies/10228159

Excellerate Bioscience Limited

Research and experimental development on biotechnology · Nottingham

ActiveUnited KingdomIncorporated 2016Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-06-30 · GBP · Company accounts

Net assets
£2,773,629
Cash
£1,651,692
Turnover
—
Profit / loss
—
Current assets
£2,499,987
Creditors < 1 year
£522,419
Equity
£2,773,629
Average employees
31

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

9 periods
Reported figures2025-06-3012 months · Company2024-06-3012 months · Company2023-06-3012 months · Company2022-06-3012 months2021-06-3012 months2020-06-3012 months2019-06-3012 months2018-06-3013 months2017-05-3112 months
Balance sheet
Net assets£2,773,629£1,927,643£1,545,068£912,989£576,919£295,213£534,912£281,161£216,927
Equity£2,773,629£1,927,643£1,545,068£912,989£576,919£295,213£534,912£281,161£216,927
Assets
Property, plant & equipment£796,061£687,055£663,064£306,955£271,454£201,498£398,111£243,384£127,515
Current assets£2,499,987£1,887,390£1,203,042£1,002,918£670,126£389,009£412,878£240,822£283,360
Cash at bank£1,651,692£1,633,420£967,068£846,397£635,538£331,145£125,395£145,586£225,694
Debtors£848,295£253,970£235,974£156,521£34,588£57,864£287,483£95,236£57,666
Liabilities
Creditors within one year£522,419£646,802£321,038£362,356£324,661£295,294£276,077£203,045£193,948
Creditors after one year———£34,528£40,000————
Net current assets£1,977,568£1,240,588£882,004£640,562£345,465£93,715£136,801£37,777£89,412
Assets less current liabilities£2,773,629£1,927,643£1,545,068£947,517£616,919£295,213£534,912£281,161£216,927
People & pay
Average employees3124211612151484
Source evidenceView filing View filing View filing View filing View filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges

No charges available in our records.

Scaleup signal
OECD growth threshold met
25% employee CAGR